Tenderwize
Back to tender search

Pharmaceutical Products

Amgros I/S·København Ø, Denmark·DKK 1564M | EUR 209.2M·Deadline Sep 03, 2026 · 34 days left·Open·Supplies
High valueStructured notice only
Original notice title

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

80/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

80 / 100

Complexity

30 / 100

Risk factors

The stated estimated quantities are indicative only. Actual demand may be lower or higher based on patient needs and tr...

The framework is non-exclusive and without purchase obligation. The buyer may purchase from other sources even if you w...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • DKK 1564M estimated value
  • Supplies contract
  • 2 lots
  • Duration until Dec 2028
  • Supply of Daratumumab (ATC L01FC01) in two different formulations and strengths.
  • Lot 1: 1800 mg injection, estimated 610,073 units.
Show full summary

This is an open tender (framework agreement) by Amgros I/S for the supply of pharmaceutical products (Daratumumab) to Danish public hospital pharmacies. The tender is divided into two separate lots, each representing a different product form/dosage. Award is based solely on price (100% weight). No minimum eligibility requirements are imposed. The total estimated framework value is DKK 1,564,000,000 (approx. EUR 208,873,981). The procurement is EU-funded and conducted under Directive 2014/24/EU. Submission is electronic via a portal, with a deadline of 2026-09-03. Important: no procurement documents were analyzed; all data comes from the structured notice and XML notice.

Risks

The stated estimated quantities are indicative only. Actual demand may be lower or higher based on patient needs and tr...

The framework is non-exclusive and without purchase obligation. The buyer may purchase from other sources even if you w...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Open procedure for a framework agreement.
  • Variants are not allowed.

Administrative

  • Tenders must be submitted electronically via Amgros procurement portal.

Requirements may be incomplete.

Award Criteria

Lot 1

100% price – lowest price wins.100%

Lot 2

100% price – lowest price wins.100%

Buyer

Location

København Ø, DNK

Buyer profile

Open profile

Identifier

14479880

Activity

Health

Lots (2)

LOT-0001

Tender No. 1

Supply of Daratumumab injection 1800 mg, estimated 610,073 units. Framework agreement with no purchase obligation. Real consumption may vary significantly from estimates.

SuppliesFrameworkEU fundedElectronic submission

EUR 209.2M

Estimated value

Location

DK011, Denmark

Duration

Dec 2026 - Dec 2028

Category

Pharmaceutical products

Award Criteria

Price

LOT-0002

Tender No. 2

Supply of Daratumumab infusion 20 mg/ml in two pack sizes (5 ml and 20 ml), combined estimated 712 units. Framework agreement with no purchase obligation. Real consumption may vary.

SuppliesFrameworkEU fundedElectronic submission

EUR 209.2M

Estimated value

Location

DK011, Denmark

Duration

Dec 2026 - Dec 2028

Category

Pharmaceutical products

Award Criteria

Price

Procurement Details

Publication date
09 Jul 2026
Languages
Danish, Swedish

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
477000-2026

Documents (1)

Similar tenders